Skip to main content
Caplight Logo









River BioMedics

River BioMedics

Private
EnschedeHealthcare & Life Scienceshttps://riverbiomedics.com/

Last Round

Grant

Jul 5, 2023

Total Funding Raised

$5.78M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

River BioMedics is a biotechnology company that develops 3D human cardiac models for target validation and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

3D cardiac modelsheart-on-a-chiphiPSChuman induced pluripotent stem cellspreclinical drug discoverycardiovascular disease modelsorgan-on-a-chipin vitro cardiac tissuedrug efficacy testingpreclinical translationbiotech servicesassay developmentcardiac safety screeningmicrofluidicspredictive toxicology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

River BioMedics Comparables

Compare River BioMedics with similar companies based on industry and business-model similarity.

River BioMedics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HeartBeat.bio AG
87%
Ncardia
81%
BiomimX
81%

River BioMedics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 5, 2023
GrantJan 24, 2023
SeedJan 20, 2022

Key People

Founding team and executive leadership

Nicky Cooper

CEO

Executive Team

River BioMedics Investors

Notable investors and investment history

River BioMedics investors
InvestorRounds
European Innovation Council FundGrant
Libertatis Ergo HoldingGrant
First FundGrant, Seed
KIKK CapitalGrant, Seed
BioGeneration VenturesGrant, Seed
European Innovation Council FundGrant
Oost NLGrant, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 35% MoM, reaching 1.3K.

  • Sep 1, 2025

    Partnered with Harborn to accelerate AI model training for heart disease treatments.

River BioMedics Filings

Explore SEC and related filing metadata, where available.

River BioMedics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about River BioMedics's valuation, stock price, and market status.

Is River BioMedics a public or private company?

River BioMedics is a private company.

What is the current stock price of River BioMedics?

River BioMedics is a private company with no public stock price. No recent secondary market data is available.

How much is River BioMedics worth (valuation)?

Valuation information for River BioMedics is not publicly available.

Can I buy River BioMedics stock?

River BioMedics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was River BioMedics's last funding round?

River BioMedics's most recent funding round was Seed on July 5, 2023.

Who are the main investors in River BioMedics?

Key investors in River BioMedics include First Fund, KIKK Capital, Oost NL.

Will River BioMedics IPO soon?

No public IPO plans have been announced for River BioMedics.

How can I track River BioMedics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor River BioMedics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEnschede
Employee Range10
Year Founded2020
Last FundingJul 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?